Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-510 in advanced renal cell carcinoma
NCT00073125Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- May 2003
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of abt-510 in renal cell carcinoma (RCC), sponsored by Abbott Laboratories. Started May 2003; status: completed.
02
Drugs
abt-510
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00073125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073125.